
InVitae Corp is a diagnostics & research business based in the US. InVitae shares (NVTA) are listed on the NYSE and all prices are listed in US Dollars. InVitae employs 2,900 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in InVitae
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – NVTA – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Our top pick for
Beginners

Our top pick for
Building a portfolio

Our top pick for
Advanced traders

InVitae stock price (NYSE: NVTA)
Use our graph to track the performance of NVTA stocks over time.InVitae shares at a glance
Latest market close | $3.07 |
---|---|
52-week range | $2.08 - $35.51 |
50-day moving average | $4.12 |
200-day moving average | $13.93 |
Wall St. target price | $13.59 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-2.06 |
Buy InVitae shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy InVitae stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
InVitae price performance over time
Historical closes compared with the close of $3.07 from 2022-06-24
1 week (2022-06-17) | 37.67% |
---|---|
1 month (2022-05-27) | -23.63% |
3 months (2022-03-23) | N/A |
6 months (2021-12-27) | -79.78% |
1 year (2021-06-25) | -91.09% |
---|---|
2 years (2020-06-26) | -88.99% |
3 years (2019-06-27) | 21.55 |
5 years (2017-06-26) | 9.64 |
InVitae financials
Revenue TTM | $480.5 million |
---|---|
Gross profit TTM | $111.8 million |
Return on assets TTM | -11.74% |
Return on equity TTM | -17.29% |
Profit margin | -93.93% |
Book value | $12.43 |
Market capitalisation | $644.3 million |
TTM: trailing 12 months
InVitae share dividends
We're not expecting InVitae to pay a dividend over the next 12 months.
InVitae share price volatility
Over the last 12 months, InVitae's shares have ranged in value from as little as $2.08 up to $35.51. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while InVitae's is 1.9047. This would suggest that InVitae's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
InVitae overview
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California. .
InVitae in the news
Signify (SGFY) Stock Jumps 6%: Will It Continue to Soar?
Why Invitae Stock Plummeted by 15% Today
Why I Sold My Invitae Stock
Frequently asked questions
What percentage of InVitae is owned by insiders or institutions?Currently 1.199% of InVitae shares are held by insiders and 80.637% by institutions. How many people work for InVitae?
Latest data suggests 2,900 work at InVitae. When does the fiscal year end for InVitae?
InVitae's fiscal year ends in December. Where is InVitae based?
InVitae's address is: 1400 16th Street, San Francisco, CA, United States, 94103 What is InVitae's ISIN number?
InVitae's international securities identification number is: US46185L1035 What is InVitae's CUSIP number?
InVitae's Committee on Uniform Securities Identification Procedures number is: 46185L103
More guides on Finder
-
How to buy Intchains Group (ICG) stock when it goes public
Everything we know about the Intchains Group IPO, plus information on how to buy in.
-
How to buy Biostage (BSTG) stock when it goes public
Everything we know about the Biostage IPO, plus information on how to buy in.
-
How to buy Wang & Lee Group (WLGS) stock when it goes public
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
-
How to buy OptMed (OMED) stock when it goes public
Everything we know about the OptMed IPO, plus information on how to buy in.
-
How to buy Lichen China (LICN) stock when it goes public
Everything we know about the Lichen China IPO, plus information on how to buy in.
-
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
-
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
-
How to buy Warrantee (WRNT) stock when it goes public
Everything we know about the Warrantee IPO, plus information on how to buy in.
-
How to buy Treasure Global (TGL) stock when it goes public
Everything we know about the Treasure Global IPO, plus information on how to buy in.
-
How to buy BIOLIFE4D (SAVU) stock when it goes public
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.
Ask an Expert